BONS

COM:BONUS-BIO

Bonus Biogroup

  • Stock

Last Close

11.50

21/11 15:24

Market Cap

181.03M

Beta: -

Volume Today

476.30K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
748.50K
-
582.50K
22.18%
932.50K
60.09%
1.20M
28.79%
1.13M
5.58%
1.35M
19.09%
1.52M
12.51%
2.78M
82.72%
2.97M
7.08%
1.68M
43.54%
average receivables
book value per share
0.04
-
0.00
91.89%
-0.01
316.32%
-0.03
386.64%
-0.02
21.99%
-0.01
54.47%
-0.04
300.06%
0.08
273.85%
0.15
87.17%
0.09
37.72%
capex per share
-0.01
-
-0.00
68.15%
-0.00
84.56%
-0.00
99.25%
-0.00
26.72%
-0.00
15.99%
-0.00
49.20%
-0.00
5.60%
-0.01
1,455.69%
-0.01
2.55%
capex to depreciation
-6.53
-
-1.17
82.11%
-0.18
84.59%
-0.47
158.87%
-1.65
254.25%
-1.73
4.89%
-0.17
89.97%
-0.24
37.10%
-3.94
1,553.28%
-2.40
39.04%
-0.30
87.56%
capex to operating cash flow
0.19
-
0.07
64.47%
0.01
83.91%
0.02
81.96%
0.02
14.65%
0.03
11.62%
0.01
43.85%
0.02
13.12%
0.15
803.92%
0.22
52.06%
0.03
85.92%
capex to revenue
cash per share
0.03
-
0.01
62.17%
0.02
56.75%
0.01
70.84%
0.01
75.01%
0.03
190.13%
0.00
98.87%
0.04
11,810.09%
0.14
235.98%
0.09
37.07%
days of inventory on hand
days payables outstanding
505.48
-
177.49
64.89%
205.92
16.02%
434.22
110.87%
284.98
34.37%
353.66
-
355.82
0.61%
211.67
40.51%
days sales outstanding
debt to assets
0.15
-
0.84
-
0.10
88.08%
0.12
18.15%
0.16
35.32%
0.25
55.17%
debt to equity
1.11
-
-0.43
-
0.17
139.22%
0.15
12.92%
0.21
44.90%
0.38
79.64%
dividend yield
earnings yield
-0.24
-
-0.24
0.50%
-0.09
61.34%
-0.12
30.07%
-0.14
17.82%
-0.18
24.91%
-0.16
8.33%
-0.12
29.23%
-0.12
6.88%
-0.30
142.70%
enterprise value
39.35M
-
45.61M
15.90%
140.31M
207.62%
131.25M
6.45%
138.99M
5.90%
96.61M
30.50%
142.05M
47.05%
179.73M
26.52%
662.59M
268.65%
87.51M
86.79%
-1.78M
102.03%
enterprise value over ebitda
-4.13
-
-4.25
2.79%
-10.87
155.96%
-8.50
21.76%
-6.96
18.14%
-5.32
23.64%
-7.09
33.44%
-9.77
37.77%
-9.88
1.12%
-3.23
67.35%
ev to operating cash flow
-5.16
-
-5.77
11.86%
-17.39
201.45%
-13.64
21.58%
-11.76
13.79%
-7.19
38.80%
-10.83
50.57%
-11.41
5.37%
-16.63
45.71%
-3.04
81.74%
0.07
102.22%
ev to sales
free cash flow per share
-0.05
-
-0.04
19.62%
-0.04
9.12%
-0.04
10.47%
-0.05
10.84%
-0.05
4.18%
-0.04
10.52%
-0.04
6.48%
-0.08
94.07%
-0.06
28.09%
free cash flow yield
-0.23
-
-0.18
19.97%
-0.06
68.90%
-0.07
31.28%
-0.09
15.31%
-0.13
53.32%
-0.10
25.40%
-0.08
14.01%
-0.06
25.45%
-0.27
335.61%
graham net net
0.02
-
-0.01
125.35%
-0.01
102.18%
-0.04
197.43%
-0.04
6.18%
-0.02
53.50%
-0.07
306.63%
-0.01
82.39%
0.10
968.12%
0.06
44.58%
graham number
0.21
-
0.06
71.54%
0.10
56.32%
0.22
130.79%
0.21
6.00%
0.13
37.83%
0.27
109.74%
0.31
15.68%
0.71
128.21%
0.36
50.05%
income quality
0.79
-
0.71
10.31%
0.60
15.03%
0.60
0.05%
0.59
2.41%
0.72
22.43%
0.59
17.73%
0.72
21.27%
0.44
38.15%
0.74
68.34%
0.93
24.28%
intangibles to total assets
0.00
-
0.00
145.92%
0.00
42.38%
0.00
8.41%
0.00
56.73%
0
100%
0
0
0
0.00
Infinity%
0.00
1.98%
interest coverage
-403.21
-
-414.07
2.69%
-219.64
46.96%
-192.33
12.44%
-300.45
56.22%
-50.69
83.13%
-45.45
10.32%
-47.66
4.85%
-113.77
138.73%
-41.58
63.45%
interest debt per share
0.00
-
0.00
2,415.93%
0.00
91.78%
0.00
24.91%
0.00
27.37%
0.00
397.08%
0.02
1,512.37%
0.01
31.75%
0.02
58.00%
0.02
7.30%
inventory turnover
invested capital
1.11
-
-0.43
-
0.17
139.22%
0.15
12.92%
0.21
44.90%
0.38
79.64%
market cap
40.13M
-
46.59M
16.10%
144.72M
210.65%
132.65M
8.34%
141.72M
6.83%
105.25M
25.74%
136.28M
29.49%
190.66M
39.90%
729.69M
282.71%
129.19M
82.30%
net current asset value
4.94M
-
-739K
114.96%
-2.33M
215.43%
-8.18M
251.05%
-7.31M
10.67%
-4.25M
41.90%
-20.40M
380.41%
-4.02M
80.32%
61.11M
1,621.64%
36.21M
40.74%
10.86M
70.02%
net debt to ebitda
0.08
-
0.09
11.83%
0.34
276.04%
0.09
73.43%
0.14
50.35%
0.48
248.39%
-0.29
160.61%
0.59
306.27%
1.00
68.37%
1.54
53.50%
net income per share
-0.06
-
-0.06
0.06%
-0.06
12.97%
-0.07
9.45%
-0.08
13.25%
-0.07
15.13%
-0.07
9.96%
-0.06
23.02%
-0.16
178.24%
-0.06
59.94%
operating cash flow per share
-0.04
-
-0.04
10.36%
-0.04
4.01%
-0.04
9.51%
-0.05
10.53%
-0.05
3.91%
-0.04
9.54%
-0.04
6.65%
-0.07
72.10%
-0.05
32.56%
payables turnover
0.72
-
2.06
184.80%
1.77
13.81%
0.84
52.58%
1.28
52.37%
1.03
-
1.03
0.61%
1.72
68.10%
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-1.19
-
-2.49
108.75%
-2.34
5.76%
-5.55
137.00%
-3.62
34.72%
-1.84
49.12%
-3.18
72.51%
-0.43
86.54%
-0.86
101.68%
-0.52
39.89%
revenue per share
roe
-1.51
-
-18.55
1,132.70%
9.69
152.22%
2.18
77.51%
3.16
45.17%
5.90
86.40%
1.62
72.51%
-0.72
144.28%
-1.07
48.66%
-0.69
35.67%
roic
-1.49
-
-8.75
487.32%
9.65
210.20%
2.18
77.36%
3.15
44.37%
5.83
84.95%
10.53
80.49%
-0.47
104.50%
-0.57
19.88%
-0.55
3.57%
sales general and administrative to revenue
shareholders equity per share
0.04
-
0.00
91.89%
-0.01
316.32%
-0.03
386.64%
-0.02
21.99%
-0.01
54.47%
-0.04
300.06%
0.08
273.85%
0.15
87.17%
0.09
37.72%
stock based compensation to revenue
tangible asset value
6.43M
-
589K
90.85%
-1.40M
337.69%
-7.37M
426.36%
-6.39M
13.30%
-3.18M
50.27%
-13.72M
331.89%
30.68M
323.63%
84.43M
175.16%
56.35M
33.26%
29.28M
48.04%
tangible book value per share
0.04
-
0.00
91.89%
-0.01
316.32%
-0.03
386.64%
-0.02
21.99%
-0.01
54.47%
-0.04
300.06%
0.08
273.85%
0.15
87.17%
0.09
37.72%
working capital
4.94M
-
-739K
114.96%
-2.33M
215.43%
-8.18M
251.05%
-7.31M
10.67%
-3.36M
54.01%
-15.15M
350.54%
363K
102.40%
72.23M
19,798.07%
46.81M
35.19%
20.53M
56.14%

All numbers in (except ratios and percentages)